Nc1nonc1-n1nnc(C(=O)N/N=C/c2cccc(F)c2)c1-c1ccc2c(c1)OCO2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?